112 related articles for article (PubMed ID: 206348)
1. Search for disease-related cytotoxicity in mammary tumor patients.
Bakacs T; Klein E; Ljungström KG
Cancer Lett; 1978 Apr; 4(4):191-7. PubMed ID: 206348
[TBL] [Abstract][Full Text] [Related]
2. Decreased T-lymphocytes in patients with mammary cancer.
Keller SE; Ioachim HL; Pearse T; Siletti DM
Am J Clin Pathol; 1976 Apr; 65(4):445-9. PubMed ID: 178170
[TBL] [Abstract][Full Text] [Related]
3. EBV-related cytotoxicity of Fc receptor negative T lymphocytes separated from the blood of infectious mononucleosis patients.
Bakacs T; Svedmyr E; Klein E
Cancer Lett; 1978 Apr; 4(4):185-9. PubMed ID: 206347
[TBL] [Abstract][Full Text] [Related]
4. Identification of breast cancer transcortin and its inhibitory role in cell-mediated immunity.
Amaral L; Werthamer S
Nature; 1976 Aug; 262(5569):589-90. PubMed ID: 8726
[No Abstract] [Full Text] [Related]
5. Characterization of human lymphocyte subpopulations for cytotoxicity against tumor-derived monolayer cultures.
Bakács T; Gergely P; Cornain S; Klein E
Int J Cancer; 1977 Apr; 19(4):441-9. PubMed ID: 321366
[TBL] [Abstract][Full Text] [Related]
6. Transitional cell carcinoma: lymphocyte-mediated cytotoxicity.
Troye M; Pape GR
Natl Cancer Inst Monogr; 1978 Dec; (49):85-7. PubMed ID: 311895
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a monoclonal antibody reactive with a subset of human breast tumors.
Yuan D; Hendler FJ; Vitetta ES
J Natl Cancer Inst; 1982 May; 68(5):719-28. PubMed ID: 6279951
[TBL] [Abstract][Full Text] [Related]
8. Study of the tumor cell-lymphocyte interaction in patients with breast cancer.
Deodhar SD; Crile G; Esselstyn CB
Cancer; 1972 May; 29(5):1321-5. PubMed ID: 4336633
[No Abstract] [Full Text] [Related]
9. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells--III. Stimulatory and inhibitory effects of ionizing radiation.
Dean DM; Pross HF; Kennedy JC
Int J Radiat Oncol Biol Phys; 1978; 4(7-8):633-41. PubMed ID: 711535
[No Abstract] [Full Text] [Related]
10. In vitro generation of cytotoxic lymphocytes by tumor extracts of transitional cell carcinoma.
Morales A
Natl Cancer Inst Monogr; 1978 Dec; (49):173-4. PubMed ID: 748769
[TBL] [Abstract][Full Text] [Related]
11. [The secretory IgA system and breast cancer].
Rossiello R; Carriero MV; Bevilacqua AM; Di Costanzo MR; Di Bonito M
Pathologica; 1984; 76(1042):201-9. PubMed ID: 6089080
[No Abstract] [Full Text] [Related]
12. CEA-like material in cytosols from human breast carcinomas. Correlation with biochemical and pathologic parameters.
Duffy MJ; O'Connell M; O'Sullivan F; McKenna B; Allen MA; McDonnell L
Cancer; 1983 Jan; 51(1):121-3. PubMed ID: 6295590
[TBL] [Abstract][Full Text] [Related]
13. Immunologic relationship between breast carcinoma and benign breast disease as detected by the leukocyte migration inhibition assay.
Cannon GB; McCoy JL; Jerome LJ; Reddick R; Alford C; Tinley V; Herberman RB
J Natl Cancer Inst; 1978 Nov; 61(5):1181-6. PubMed ID: 280705
[TBL] [Abstract][Full Text] [Related]
14. Frequency of association of mammary tumor glycoprotein antigen and other markers with human breast tumors.
Leung JP; Bordin GM; Nakamura RM; DeHeer DH; Edgington TS
Cancer Res; 1979 Jun; 39(6 Pt 1):2057-61. PubMed ID: 221100
[No Abstract] [Full Text] [Related]
15. Antigenic cross-reactivity between benign and malignant neoplasms of the human breast.
Avis F; Mosonov I; Haughton G
J Natl Cancer Inst; 1974 Apr; 52(4):1041-9. PubMed ID: 4826577
[No Abstract] [Full Text] [Related]
16. Serum factors in tumor-free patients cancelling the blocking of cell-mediated tumor immunity.
Hellström I; Hellström KE; Sjögren HO; Warner GA
Int J Cancer; 1971 Sep; 8(2):185-91. PubMed ID: 4332366
[No Abstract] [Full Text] [Related]
17. An antitumor antibody in normal human serum: reaction of anti-T with breast carcinoma cells.
Howard DR; Taylor CR
Oncology; 1980; 37(3):142-8. PubMed ID: 6244524
[TBL] [Abstract][Full Text] [Related]
18. Unrestricted T-cell receptor V-region gene repertoire in tumor-infiltrating lymphocytes from human breast carcinomas.
Mathoulin MP; Xerri L; Jacquemier J; Adelaide J; Parc P; Hassoun J
Cancer; 1993 Jul; 72(2):506-10. PubMed ID: 8391381
[TBL] [Abstract][Full Text] [Related]
19. Establishment of monoclonal antibodies reactive with epithelial and myoepithelial cells in the breast.
Imai S; Sekiya N; Morimoto J; Kiyozuka Y; Tsubura Y; Sakamoto G
Acta Pathol Jpn; 1986 Sep; 36(9):1319-26. PubMed ID: 3024448
[TBL] [Abstract][Full Text] [Related]
20. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors.
Kufe D; Inghirami G; Abe M; Hayes D; Justi-Wheeler H; Schlom J
Hybridoma; 1984; 3(3):223-32. PubMed ID: 6094338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
